Jeffrey Klausner, MD
Enriched profileClinical Professor of Medicine, Infectious Diseases, and Population and Public Health Sciences · Keck School of Medicine of the University of Southern California
Jeffrey Klausner is Clinical Professor of Medicine, Infectious Diseases, and Population and Public Health Sciences at Keck School of Medicine of the University of Southern California. OpenAlex indexes 981 publications with 29,564 citations (h-index 84); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Jeffrey Klausner, MD, is Clinical Professor of Medicine, Infectious Diseases, and Population and Public Health Sciences at Keck School of Medicine of the University of Southern California. The public record shows 981 publications with 29,564 citations (h-index 84), centered on HIV/AIDS Research and Interventions, Reproductive tract infections research, HIV, Drug Use, Sexual Risk. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 11 companies, 15 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · International journal of STD & AIDS
- Top research focus: HIV/AIDS Research and Interventions
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 508.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mlo-online.com ↗
- Advisor to U.S. CDC
National Institutes of Health, and World Health Organization on sexually transmitted disease issues
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mlo-online.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Linezolid for Syphilis Pilot Study
Sponsor: University of Southern California
- Cefixime Clinical Trial
Sponsor: University of Southern California
Industry payments
Updated 18 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ROCHE DIAGNOSTICS INTERNATIONAL LTDProgram year20251 payment
- BioFire Diagnostics, LLCProgram year20251 payment
- Visby Medical, Inc.Program year20251 payment
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Gabapentinoids100%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
15 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
University of Southern California
FY2026$636,954R01AI155217 - Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design
University of Southern California
FY2026$414,444R01AI139265 - V-STAR - Vietnam Research Training Program on Sexually Transmitted Diseases and Antimicrobial Resistance
University of Southern California
FY2026$246,041D43TW012743
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Field Performance and usability of a novel molecular point-of-care assay for Chlamydia trachomatis and Neisseria gonorrhoeae detection.
International journal of STD & AIDS
Article2026 - Maternal and congenital syphilis at a national referral center in Peru, 2023-2025.
International journal of STD & AIDS
Article2026 - Clinician-observed genital lesions among pregnant women in a high HIV/sexually transmitted infection prevalence setting.
International journal of STD & AIDS
Article2026 - Perceptions of acceptability and preferences surrounding a hypothetical syphilis vaccine in Lima, Peru.
International journal of STD & AIDS
Article2026
Most-cited works
by citation count (OpenAlex)- 01Clinical Metagenomic Sequencing for Diagnosis of Meningitis and EncephalitisArticle1,058 citations2019
- 02
- 03
- 04Accepted but UnacceptableArticle442 citations2015
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →webmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Editorial & leadership roles
journal and society appointments- Senior Editor
Current STD Diagnosis and Management (McGraw-Hill textbook)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
- Director
Klausner Research Group
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sloanfilmsummit.org ↗
Secondary affiliations
appointments beyond the home institution- Branch Chief for HIV and TB
CDC Pretoria, South Africa (2009-2011), directing the South African PEPFAR program
2011verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Deputy Health Officer and Director of STD Prevention and Control Services
San Francisco Department of Public Health
2009verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Faculty member in AIDS and Infectious Diseases divisions
UCSF School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Attending Physician
San Francisco General Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ourki.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute